Clinical Trials in Ohio

Showing 14941-14960 of 20,938 trials

Prandial Insulin Dosing in Hospitalized Patients

NCT01101867

The purpose of this study is to determine whether mealtime insulin results in better control of blood sugar than a fixed meal dose in hospitalized patients.

DiabetesAdmitting HospitalNon-critically Ill

Kathleen Dungan126 participantsStarted Jun 2010

Columbus, Ohio, United States

UNKNOWN32 miles

Biomarkers for Gynecologic Cancer

NCT02178462

A novel blood metabolic biomarker, AminoIndexTM (gynecological), was developed for gynecological cancers from over 400 Japanese patient's plasma free amino acid profiles (PFAAs) by a rapid and sensitive LC-MS (Liquid Chromatography - Mass Spectrometry), followed by multivariate statistical analyses. However, further studies to assess whether this biomarker demonstrates the same performance characteristics in non-Japanese populations for cancer is yet to be determined.

Ovarian CancerEndometrial CancerBenign Gynecological Disease

Ajinomoto Co., Inc.153 participantsStarted Jun 2014

Columbus, Ohio, United States

COMPLETEDPhase 132 miles

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

NCT01460134

This is a study of CDX-1127, a therapy that targets the immune system and may act to promote anti-cancer effects. The study enrolls patients with hematologic cancers (certain leukemias and lymphomas), as well as patients with select types of solid tumors.

CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more

Celldex Therapeutics90 participantsStarted Oct 2011

Scottsdale, Arizona, United States • Stanford, California, United States • Rochester, Minnesota, United States +7 more locations

Prandial Insulin Dosing in Hospitalized Patients

Biomarkers for Gynecologic Cancer

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Find Trials by Condition in Ohio

Lesinurad and Febuxostat Combination Extension Study in Gout

Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular Lymphoma

NOLAN: Naproxen or Loratadine and Neulasta

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis

Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients

DNS-7801 vs. Placebo in Parkinson's Disease

A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

Safety and Tolerability Study of an Edible Colon Preparation

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

AngioDefender Versus Brachial Artery Ultrasound Imaging

Ph II Study of Perifosine for Patients With Carcinoma of the Kidney

Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis

A Study of DCC-2701 in Participants With Advanced Solid Tumors